financetom
Business
financetom
/
Business
/
Utility Evergy misses quarterly profit estimates on lower demand, higher costs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Utility Evergy misses quarterly profit estimates on lower demand, higher costs
May 26, 2025 4:06 AM

May 8 (Reuters) - Evergy Inc ( EVRG ) missed Wall Street

estimates for first-quarter profit on Wednesday, as the utility

was hurt by higher costs and lower demand due to an unplanned

maintenance shutdown by a large customer.

Higher-for-longer interest rates raise borrowing costs for

power companies, which usually need more capital for

maintaining and upgrading grid infrastructure.

The company's interest expenses rose 14.5% to $152.5 million

in the quarter, while total operating expenses increased to

$1.08 billion.

Evergy ( EVRG ) also said its industrial demand decreased because an

unnamed large customer had an unplanned maintenance shutdown. It

said the customer is expected produce at near-normal levels this

month.

Still, Evergy's ( EVRG ) total revenue for the quarter rose 3.3% from

a year ago to $1.37 billion.

Its total retail sales for the first-quarter were up 1.6%

from a year earlier to $1.10 billion. A

colder-than-expected-winter increased electricity and gas

consumption during the quarter, as residences and businesses had

more heating demand.

Evergy ( EVRG ) said it expects strong commercial and industrial load

growth as Meta and Panasonic ( PCRFF ) ramp up

operations in the second half of this year.

Evergy ( EVRG ) said in February it has secured customers including

Google, Meta and Panasonic ( PCRFF ) for data centers and

advanced manufacturing.

The utility sees year-over-year load growth in the third

quarter and fourth quarter of 3% to 5% for commercial and 6% to

8% for industrial.

Evergy ( EVRG ) provides power to 1.7 million customers in Kansas and

Missouri through its operating subsidiaries Evergy Kansas

Central, Evergy Metro and Evergy Missouri West.

On an adjusted basis, the company reported a profit of 54

cents per share for the first quarter, missing analysts'

estimates of 66 cents per share, according to data compiled by

LSEG.

The company reaffirmed its annual forecast for adjusted

earnings of between $3.92 per share and $4.12 per share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exxon group's eighth Guyana project to produce up to 1.5 bcfd of gas
Exxon group's eighth Guyana project to produce up to 1.5 bcfd of gas
Mar 11, 2025
GEORGETOWN, March 11 (Reuters) - The eighth energy project in Guyana of a consortium led by U.S. major Exxon Mobil ( XOM ) will produce up to 1.5 billion cubic feet per day (bcfd) of natural gas and 290,000 barrels per day on condensate through a floating production facility that will have capacity to export the fuel, the group told...
RB Global Acquires J.M. Wood Auction
RB Global Acquires J.M. Wood Auction
Mar 11, 2025
08:01 AM EDT, 03/11/2025 (MT Newswires) -- RB Global ( RBA ) said Tuesday it entered into a definitive agreement to acquire J.M. Wood Auction. The transaction is expected to be completed in Q2, subject to customary closing conditions, including required regulatory clearances. Financial terms of the deal were not disclosed. RB Global ( RBA ) said the acquisition of...
Arvinas, Pfizer Say Vepdegestrant Trial Meets Primary Endpoint in Breast Cancer With ESR1 Mutations
Arvinas, Pfizer Say Vepdegestrant Trial Meets Primary Endpoint in Breast Cancer With ESR1 Mutations
Mar 11, 2025
08:02 AM EDT, 03/11/2025 (MT Newswires) -- Arvinas ( ARVN ) and Pfizer ( PFE ) said Tuesday that a phase 3 clinical trial of vepdegestrant monotherapy as an investigational treatment for advanced or metastatic breast cancer met its primary endpoint in the estrogen receptor 1-mutant population, but did not reach statistical significance in progression-free survival improvement in the intent-to-treat...
Tilray Medical Introduces High THC, High Terpene Genetics to German Medical Cannabis Market
Tilray Medical Introduces High THC, High Terpene Genetics to German Medical Cannabis Market
Mar 11, 2025
08:01 AM EDT, 03/11/2025 (MT Newswires) -- Tilray Medical, a division of Tilray Brands ( TLRY ), (TLRY.TO) on Tuesday said it is introducing in Germany the Tilray Craft brand, a new extension of the Tilray Medical brand. Tilray Craft is being introduced to address the needs of patients in Germany for flower-based medical cannabis with higher THC and higher...
Copyright 2023-2026 - www.financetom.com All Rights Reserved